29.99 USD
↗ 1.69 (5.97%)AT CLOSE (03:59 PM EDT)
Vera Therapeutics, Inc. Class A Common Stock
VERANASDAQ • USD
30.27
↗ 0.28 (0.94%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
30.27
↗ 0.28 (0.94%)
Market: CLOSED
Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $30.00 per share. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, VERA trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 27, 2026.
Open?$28.35
High?$30.02
Low?$28.21
Prev. Close?$28.30
Volume?1.1M
Avg. Volume?2.0M
VWAP?$29.62
Rel. Volume?0.55x
Bid / Ask
Bid?$29.50 × 100
Ask?$31.05 × 100
Spread?$1.55
Midpoint?$30.28
Valuation & Ratios
Market Cap?2.2B
Shares Out?72.1M
Float?63.2M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?5.30
EPS?-$5.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Address
2000 SIERRA POINT PARKWAY, SUITE 1200
BRISBANE, CA 94005
Phone: 650-770-0077
BRISBANE, CA 94005
Phone: 650-770-0077
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?99
Momentum?23
Short Sent.?55
Piotroski F-Score?0/9Weak
Altman Z-Score?5.67Safe
Confidence?52%Low
Short InterestSqueeze Risk
Short % of Float?21.49%Squeeze Risk
Short Interest?13.6M
Days to Cover?7.2
Free Float63.2M
Avg Daily Volume1.9M
Settlement Date2026-10-15
Financial Health
Current Ratio?10.92Strong
Quick Ratio?10.92Strong
Cash Ratio?1.01Strong
Debt/Equity?0.18Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?5.30FAIR▾
Peers100
S&P35
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.3CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-98.9%WEAK▾
S&P3
ROA?-75.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-338911000
Enterprise Value?$2.2B
Fundamentals ratios updated end of day